Recombinant Streptococcus equi subsp. equi tRNA pseudouridine synthase A (truA)

Shipped with Ice Packs
In Stock

Description

Overview of tRNA Pseudouridine Synthases in Bacteria

Pseudouridine synthases are enzymes responsible for post-transcriptional RNA modification, including tRNA maturation. These enzymes catalyze the isomerization of uridine to pseudouridine (Ψ), enhancing RNA stability and translational fidelity. While the search results do not specify TruA in S. equi, they highlight related research on pseudouridine synthases:

  • TruB1 in Humans: A study demonstrated that TruB1 regulates miRNA let-7 maturation through RNA binding, independent of its pseudouridylation activity . This suggests that pseudouridine synthases can have non-catalytic roles in RNA metabolism.

  • Homologs in Streptococci: Although not explicitly mentioned for S. equi, homologs of tRNA-modifying enzymes (e.g., TruB, TruA) are conserved across streptococcal species. Their roles in bacterial physiology (e.g., stress response, virulence) remain underexplored in the provided sources.

Recombinant Protein Development in S. equi

While TruA is not discussed, multiple studies detail recombinant protein strategies for S. equi vaccines and diagnostics:

Table 1: Key Recombinant Proteins in S. equi Research

ProteinFunctionApplicationEfficacy/OutcomeSource
SeMAntiphagocytic M-proteinDiagnostic ELISA antigenHigh specificity for serodiagnosis
FNZ, SFS, EAGFibronectin/IgG-binding proteinsSubcutaneous/intranasal vaccineReduced nasal colonization in mice
Multi-componentSurface proteins + IgG endopeptidasesEquine vaccine6/7 horses protected from strangles

These efforts highlight the feasibility of producing recombinant S. equi proteins for biomedical applications, though TruA has not been targeted in such studies.

Gaps in S. equi TruA Research

The absence of direct data on TruA in S. equi suggests:

  • Functional Uncharacterization: TruA may not yet be linked to virulence or essential metabolic pathways in S. equi.

  • Comparative Genomics: Homologs of TruA in other streptococci (e.g., S. pyogenes) are often annotated as conserved tRNA-modifying enzymes, but their roles in pathogenesis remain speculative.

Future Directions

  • Gene Cloning: TruA could be cloned and expressed recombinantly using methods similar to those described for SeM or FNZ .

  • Enzymatic Assays: Activity could be tested using tRNA substrates, as shown for human TruB1 .

  • Pathogenicity Studies: Knockout mutants could assess TruA’s role in S. equi survival or host interaction.

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but if you have specific format requirements, please note them when ordering, and we will accommodate your request.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. If dry ice is required, please contact us in advance, as additional charges apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
truA; SEQ_1954; tRNA pseudouridine synthase A; EC 5.4.99.12; tRNA pseudouridine(38-40) synthase; tRNA pseudouridylate synthase I; tRNA-uridine isomerase I
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-249
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptococcus equi subsp. equi (strain 4047)
Target Names
truA
Target Protein Sequence
MTRYKAIISY DGTLFSGFQR QSQARTVQEE IEKTLQKLTG GQGIQIHGAG RTDAGVHAYG QVIHFDLEQK RDPEKLRFAL DTQTPDDIDV ISLEIAADDF HARYHKHFKT YEFLVDIGRP KNPMMRHYAT HYPYPLDIAK MQAAIKDLVG THDFTGFTAA GTSVKNKVRT ITAATLTQDP KTGFLVFTFS GNGFLYKQVR NMVGTLLKIG NGRLPIEQIR LVLESKNRQL AGPTAAGNGL YLKEIIYEE
Uniprot No.

Target Background

Function
Forms pseudouridine at positions 38, 39, and 40 in the anticodon stem and loop of transfer RNAs.
Database Links

KEGG: seu:SEQ_1954

Protein Families
TRNA pseudouridine synthase TruA family

Q&A

How does recombinant truA differ from its native counterpart?

Recombinant truA refers to the enzyme produced through heterologous expression systems, often in model organisms such as Escherichia coli. This recombinant form is engineered to retain the enzymatic activity of its native counterpart while allowing researchers to study its structure and function under controlled conditions. Recombinant truA facilitates high-yield production, enabling detailed biochemical assays and crystallographic studies that would be challenging with native enzymes isolated directly from Streptococcus equi. Structural analyses have revealed that recombinant truA forms a dimeric complex similar to its native form, interacting with flexible regions of tRNA molecules at positions 38-40 .

What are the experimental challenges in studying truA's enzymatic activity?

Studying truA's enzymatic activity involves several challenges:

  • Substrate Specificity: TruA selectively modifies uridine residues at specific positions within tRNA molecules (positions 38-40). Ensuring the availability of correctly folded tRNA substrates is critical for accurate activity assays .

  • Structural Flexibility: TruA preferentially interacts with flexible tRNA molecules, avoiding those with rigid anticodon stem-loops. This necessitates careful selection or engineering of substrate tRNAs during experiments .

  • Crystallization Difficulties: Obtaining high-resolution crystal structures can be challenging due to the dynamic nature of enzyme-substrate interactions. Multiple crystal forms may be required to capture different conformational states .

  • Recombinant Expression: Producing active recombinant truA often requires optimization of expression conditions, including temperature, host strain selection, and purification protocols.

Addressing these challenges requires meticulous experimental design and validation using complementary techniques such as X-ray crystallography, NMR spectroscopy, and enzymatic kinetics assays.

How can structural biology techniques elucidate truA's mechanism?

Structural biology techniques such as X-ray crystallography and cryo-electron microscopy provide invaluable insights into truA's mechanism by revealing atomic-level details of enzyme-substrate interactions. Crystallographic studies have demonstrated how truA binds flexible tRNA molecules via a dimeric embrace that stabilizes the anticodon stem-loop region while flipping out uridine residues for catalytic modification . These structures highlight key residues within the active site responsible for catalysis and substrate recognition.

Additionally, comparative analyses of different crystal forms have shown conformational changes in both the enzyme and substrate during catalysis . Such findings are crucial for understanding how truA achieves specificity and efficiency in pseudouridine synthesis.

What role does truA play in the pathogenesis of Streptococcus equi subsp. equi?

TruA contributes indirectly to the pathogenesis of Streptococcus equi subsp. equi by optimizing protein synthesis through enhanced tRNA functionality. Pseudouridine modifications stabilize critical regions of tRNA molecules, ensuring accurate codon-anticodon pairing during translation . This efficiency may be particularly important under stress conditions encountered during infection when bacterial systems require rapid adaptation.

Moreover, pseudouridine modifications could influence the expression of virulence factors by modulating translational fidelity or efficiency . While direct evidence linking truA to specific pathogenic mechanisms is limited, its role in maintaining cellular homeostasis suggests it may be an important target for therapeutic interventions aimed at disrupting bacterial protein synthesis.

How can researchers design experiments to study truA's substrate specificity?

To study truA's substrate specificity:

  • Substrate Preparation: Researchers should prepare synthetic or purified tRNA substrates with known sequences and folding patterns that include uridine residues at positions 38-40.

  • Mutagenesis Studies: Site-directed mutagenesis can be used to alter specific residues within both the enzyme's active site and the substrate's target region to identify determinants of specificity.

  • Enzymatic Assays: Kinetic assays measuring pseudouridine formation can quantify activity against various substrates under different conditions.

  • Structural Analyses: Co-crystallization or cryo-EM studies can visualize enzyme-substrate complexes at atomic resolution.

  • Comparative Studies: Comparing truA activity across different bacterial species can reveal evolutionary adaptations influencing substrate preference.

These approaches provide complementary insights into how truA recognizes and modifies specific tRNA molecules.

What are common contradictions or ambiguities in data related to truA?

Contradictions or ambiguities often arise due to differences in experimental systems or methodologies:

  • Activity Assays: Variability in assay conditions (e.g., buffer composition, temperature) can lead to discrepancies in measured enzymatic activity.

  • Structural Studies: Differences in crystal forms or resolution can result in conflicting interpretations of active site architecture or substrate binding modes .

  • Biological Context: Observations made using recombinant enzymes may not fully replicate native conditions within bacterial cells.

Resolving these contradictions requires rigorous validation using standardized protocols and cross-disciplinary approaches combining biochemistry, structural biology, and computational modeling.

How can computational modeling complement experimental studies on truA?

Computational modeling provides valuable insights into truA's function by simulating enzyme-substrate interactions at atomic resolution:

  • Molecular Dynamics Simulations: These simulations can explore conformational changes during substrate binding and catalysis.

  • Docking Studies: Computational docking predicts how tRNA substrates interact with truA's active site based on structural data.

  • Energy Calculations: Binding energy analyses identify key residues contributing to substrate specificity and catalytic efficiency.

  • Evolutionary Analysis: Sequence alignment tools can compare truA homologs across species to identify conserved functional motifs.

By integrating computational predictions with experimental data, researchers can achieve a more comprehensive understanding of truA's mechanism.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.